NIH-funded research NIH-funded research

How low oxygen in tumors makes radiation less effective in esophageal and lung cancers

Official title: Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition

Funded at University of Tx Md Anderson Can Ctr · NIH-11395548 · Data updated 2026-11-12

This grant explores how low oxygen in tumors may help cancer cells resist radiation therapy, by studying a key cell-death pathway called ferroptosis and related genes.

More Hypoxia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 20, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$301,681
NIH project number5U54CA274220-05
Project IDNIH-11395548 on NIH RePORTER

Who could benefit from this research

Could help

Patients with esophageal or lung cancers, especially those whose tumors have low oxygen levels or show resistance to radiation.

Less likely to help

Patients whose tumors do not rely on ferroptosis pathways or do not exhibit hypoxia-related resistance may not benefit.

What this research studies

Researchers will study esophageal and lung cancer cells under different oxygen levels to see how ferroptosis access changes radiation sensitivity. They will use cancer cell lines engineered to alter SLC7A11 and ATF4, important players in ferroptosis, to understand how hypoxia affects treatment response. The project aims to connect tumor oxygen levels, gene activity, and the effectiveness of chemoradiation, contributing to the larger ARTI Center work. The findings could point to new strategies to overcome resistance and improve patient outcomes in tough-to-treat cancers.

Why it matters

Potential benefit: If successful, the work could lead to approaches that make radiation therapy more effective for patients with hypoxic tumors.

How similar studies have gone: Previous work in ferroptosis and hypoxia has shown promising directions, but translating to therapy remains an active area with ongoing validation.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Koong, Albert — University of Tx Md Anderson Can Ctr
  • Study coordinator: Koong, Albert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.